Vaccine GamLPV

BIOLOGICAL2 trials

Sponsors

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Conditions

Whooping Cough

Phase 1

A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine

CompletedNCT03137927

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationWhooping Cough

Start: 2017-06-13End: 2017-12-27Updated: 2017-12-28

A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationWhooping Cough

Start: 2019-06-04End: 2020-09-30Target: 50Updated: 2019-07-31

Related Papers

Immunogenicity of the drug "Live intranasal vaccine for the prevention of pertussis" (GamLPV) with a single use in healthy volunteers

Journal of microbiology epidemiology immunobiology2022-01-107 citations